OUTCOMES OF ROTATIONAL ATHERECTOMY IN CALCIFIED PROXIMAL LEFT ANTERIOR DESCENDING (LAD) LESIONS IN THE CONTEXT OF TRIPLE VESSEL DISEASE

K ASLAM; E IQBAL; FR KHAN; W SAJJAD; MS KHAN

doi:10.54112/bcsrj.v2023i1.603

Authors

K ASLAM Department of Cardiology, Lady Reading Hospital, MTI Peshawar, Pakistan
E IQBAL Department of Dermatology, Lady Reading Hospital, MTI Peshawar, Pakistan
FR KHAN Department of Cardiology, Lady Reading Hospital, MTI Peshawar, Pakistan
W SAJJAD Department of Cardiology, Lady Reading Hospital, MTI Peshawar, Pakistan
MS KHAN RHC Marghuz District Swabi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.603

Keywords:

Percutaneous Coronary Intervention, Rotational Atherectomy, Clinical Outcome, Left Anterior Descending Lesions, Triple- Vessel Disease

Abstract

Percutaneous coronary intervention (PCI) has become more complex with the advancement of medical devices. One such device is the rotational atherectomy (RA), which uses a rotating diamond-coated burr to modify calcified lesions. This makes it easier to deliver balloons and stents to specific lesions. However, there is a lack of literature regarding the success of RA in calcified proximal 'left anterior descending (LAD) lesions' following PCI. To address this gap, a study was conducted to evaluate the clinical outcomes of RA in calcified proximal LAD lesions in triple vessel disease (TVD). The study included 112 patients who underwent PCI using RA between February 2022 and November 2022 at Lady Reading Hospital, Peshawar. Data was collected using a standard report structure, including operative and follow-up details and medical and demographic features. Retrospective data was collected using medical records and interviews with patients or doctors. The ethical committee approved the study. The participants had an average age of 68.4± 0.45 years, with 85 men (75.8%) and 40 (35.7%) with diabetes mellitus. The technical success rate was 97.6%, with 20 individuals (17.8%) experiencing significant adverse cerebral and cardiac events while hospitalized. At 1.5 years, 25 (22.3%) TVFs had occurred. Independent variables such as current smoking, chronic renal disease, history of cerebrovascular attack, left ventricle ejection fraction, and left central disease were assessed to predict TVF. Based on the results, the investigation showed that rotational atherectomy in calcified proximal LAD lesions had promising success rates.

Downloads

Download data is not yet available.

References

Abdel‐Wahab, M., Baev, R., Dieker, P., Kassner, G., Khattab, A. A., Toelg, R., Sulimov, D., Geist, V., and Richardt, G. (2013). Long‐term clinical outcome of rotational atherectomy followed by drug‐eluting stent implantation in complex calcified coronary lesions. Catheterization and Cardiovascular Interventions 81, 285-291.

Ahn, S. S., Auth, D., Marcus, D. R., and Moore, W. S. (1988). Removal of focal atheromatous lesions by angioscopically guided high-speed rotary atherectomy: Preliminary experimental observations. Journal of vascular surgery 7, 292-300.

Barbato, E., Carrié, D., Dardas, P., Fajadet, J., Gaul, G., Haude, M., Khashaba, A., Koch, K., Meyer-Gessner, M., and Palazuelos, J. (2015). European expert consensus on rotational atherectomy. EuroIntervention 11, 30-36.

Benezet, J., de la Llera, L. S. D., María Cubero, J., Villa, M., Fernández-Quero, M., and Sánchez-González, Á. (2011). Drug-eluting stents following rotational atherectomy for heavily calcified coronary lesions: long-term clinical outcomes. Journal of Invasive Cardiology 23, 28.

Cortese, B., Aranzulla, T. C., Godino, C., Chizzola, G., Zavalloni, D., Tavasci, E., De Benedictis, M., Ettori, F., Presbitero, P., and Colombo, A. (2016). Drug-eluting stent use after coronary atherectomy: results from a multicentre experience–The ROTALINK I study. Journal of Cardiovascular Medicine 17, 665-672.

De Maria, G. L., Scarsini, R., and Banning, A. P. (2019). Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach? JACC: Cardiovascular Interventions 12, 1465-1478.

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., De Ferranti, S., Faiella-Tommasino, J., and Forman, D. E. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139, e1082-e1143.

Hill, J. M., Kereiakes, D. J., Shlofmitz, R. A., Klein, A. J., Riley, R. F., Price, M. J., Herrmann, H. C., Bachinsky, W., Waksman, R., and Stone, G. W. (2020). Intravascular lithotripsy for treatment of severely calcified coronary artery disease. Journal of the American College of Cardiology 76, 2635-2646.

Jinnouchi, H., Kuramitsu, S., Shinozaki, T., Kobayashi, Y., Hiromasa, T., Morinaga, T., Mazaki, T., Sakakura, K., Soga, Y., and Hyodo, M. (2015). Two-year clinical outcomes of newer-generation drug-eluting stent implantation following rotational atherectomy for heavily calcified lesions. Circulation Journal 79, 1938-1943.

Kawamoto, H., Latib, A., Ruparelia, N., Ielasi, A., D’Ascenzo, F., Pennacchi, M., Sardella, G., Garbo, R., Meliga, E., and Moretti, C. (2016). In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: the ROTATE multicentre registry. EuroIntervention 12, 1448-1456.

Lee, M. S., Gordin, J. S., Stone, G. W., Sharma, S. K., Saito, S., Mahmud, E., Chambers, J., Généreux, P., and Shlofmitz, R. (2018). Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification. Catheterization and Cardiovascular Interventions 92, 61-67.

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., and Mauri, L. (2016). 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 134, e123-e155.

Mezilis, N., Dardas, P., Ninios, V., and Tsikaderis, D. (2010). Rotablation in the drug eluting era: Immediate and long‐term results from a single center experience. Journal of interventional cardiology 23, 249-253.

Okai, I., Dohi, T., Okazaki, S., Jujo, K., Nakashima, M., Otsuki, H., Tanaka, K., Arashi, H., Okabe, R., and Nagura, F. (2018). Clinical Characteristics and Long-Term Outcomes of Rotational Atherectomy―J2T Multicenter Registry―. Circulation Journal 82, 369-375.

Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., and Smith, P. K. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Journal of the American College of Cardiology 69, 2212-2241.

Patti, A. M., Giglio, R. V., Papanas, N., Rizzo, M., and Rizvi, A. A. (2019). Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 12, 129-143.

Rathore, S., Matsuo, H., Terashima, M., Kinoshita, Y., Kimura, M., Tsuchikane, E., Nasu, K., Ehara, M., Asakura, Y., and Katoh, O. (2010). Rotational atherectomy for fibro‐calcific coronary artery disease in drug eluting stent era: Procedural outcomes and angiographic follow‐up results. Catheterization and Cardiovascular Interventions 75, 919-927.

Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., and Chew, D. P. (2015). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Kardiologia Polska (Polish Heart Journal) 73, 1207-1294.

Tamekiyo, H., Hayashi, Y., Toyofuku, M., Ueda, H., Sakuma, T., Okimoto, T., Otsuka, M., Imazu, M., and Kihara, Y. (2009). Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circulation Journal 73, 2042-2049.

Tomey, M. I., Kini, A. S., and Sharma, S. K. (2014). Current status of rotational atherectomy. JACC: Cardiovascular Interventions 7, 345-353.